Cognizant Will Acquire Zenith Technologies to Enrich Its IoT Offerings
Cognizant announced the acquisition as a first after the appointment of Brian Humphries as the IT services major’s CEO. Cognizant will buy Zenith Technologies at an undisclosed amount, primarily to bolster its IoT capabilities and to gain a foothold in the life sciences domain.
Headquartered in Ireland, Zenith Technologies is a manufacturer of life science services technology that specializes in deploying digital technologies. By leveraging its capabilities Cognizant can manage, control and optimize equipment pertaining to the manufacture of drugs as well as medical devices for heightened performance and for regulatory compliance.
The acquisition is a further extension to Cognizant’s already vast inventory that offers designing, implementation and the management of end-to-end IT systems, especially for the Biopharmaceutical and Medical Device industry.
“Industry 4.0 solutions, encompassing Internet of Things (IoT), automation and analytics, are a strategic focus area for Cognizant,” said Brian Humphries, Chief Executive Officer, Cognizant. “In acquiring Zenith Technologies, we expand Cognizant’s IoT portfolio and extend our life sciences domain expertise by becoming a single-source provider of end-to-end smart factory capabilities. Together, we are better positioned to help clients realize information and operational technology convergence in their manufacturing operations, and advance the development of life-saving drugs, biologics, specialized pharmaceuticals, and medical devices. We look forward to welcoming Zenith Technologies’ employees to Cognizant.”
“In joining Cognizant, we are bringing together two respected life sciences service provider brands with complementary technology and manufacturing operations expertise,” said Joe Haugh, Chief Executive Officer, Zenith Technologies. “It’s an exciting time for us, with the life sciences industry embracing digital transformation to enable more flexible and efficient manufacturing facilities to bring new treatments to market faster. Our combined business will drive process excellence through tighter integration of manufacturing processes and systems, the efficient harnessing of information and analytics across the manufacturing value chain, and the adoption of IoT technologies delivering manufacturing 4.0. Together, we are well-positioned to help clients more efficiently produce life-changing medicines and medical devices for patients who need them the most.”
The IT industry is seeing a surge in the life sciences sector adapting to IoT abilities such as smart factories. This is due to the fact that as research advances there is a need for complex processes and production systems to gratify end-user demand.